Current Radiotherapy Considerations for Nasopharyngeal Carcinoma

被引:26
|
作者
Ng, Wai Tong [1 ,2 ,3 ]
Chow, James C. H. [4 ]
Beitler, Jonathan J. [5 ]
Corry, June [6 ]
Mendenhall, William [7 ]
Lee, Anne W. M. [1 ,2 ]
Robbins, K. Thomas [8 ]
Nuyts, Sandra [9 ]
Saba, Nabil F. [10 ]
Smee, Robert [11 ]
Stokes, William A. [12 ]
Strojan, Primoz [13 ]
Ferlito, Alfio
机构
[1] Univ Hong Kong, Shenzhen Hosp, Clin Oncol Ctr, Shenzhen 518009, Peoples R China
[2] Univ Hong Kong, Shenzhen Hosp, Shenzhen Key Lab Canc Metastasis & Personalized Th, Shenzhen 518009, Peoples R China
[3] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Peoples R China
[4] Queen Elizabeth Hosp, Dept Clin Oncol, Hong Kong, Peoples R China
[5] Knox Cty Hlth Clin, Rockland, ME 04841 USA
[6] St Vincents Hosp, Div Radiat Oncol, GenesisCare Radiat Oncol, Melbourne, Vic 3065, Australia
[7] Univ Florida, Dept Radiat Oncol, Coll Med, Gainesville, FL 32610 USA
[8] Southern Illinois Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Springfield, IL 62794 USA
[9] Univ Leuven, KU Leuven, Univ Hosp Leuven, Dept Radiat Oncol, B-3000 Leuven, Belgium
[10] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA 30322 USA
[11] Prince Wales Canc Ctr, Dept Radiat Oncol, Sydney, NSW 2031, Australia
[12] Emory Univ, Winship Canc Inst, Dept Radiat Oncol, Sch Med, Atlanta, GA 30322 USA
[13] Inst Oncol, Dept Radiat Oncol, Ljubljana 1000, Slovenia
关键词
nasopharyngeal cancer; radiotherapy; target delineation; adaptive planning; artificial intelligence; particle therapy; INTENSITY-MODULATED RADIOTHERAPY; CLINICAL TARGET VOLUME; LYMPH-NODE DISTRIBUTION; QUALITY-OF-LIFE; RADIATION-THERAPY; ARTIFICIAL-INTELLIGENCE; INDUCTION CHEMOTHERAPY; TREATMENT OUTCOMES; PROTON THERAPY; NCIC CTG;
D O I
10.3390/cancers14235773
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Nasopharyngeal carcinoma (NPC) is commonly treated using high-dose radiotherapy. Careful radiotherapy planning is crucial for the eradication of cancer cells while avoiding injuries to normal structures. This balance is often delicate given the complex anatomic location in which NPC is situated. This article highlights the considerations, practical pearls, and recent advances in the precise delivery of radiotherapy in NPC patients. Radiotherapy is the primary treatment modality for nasopharyngeal carcinoma (NPC). Successful curative treatment requires optimal radiotherapy planning and precise beam delivery that maximizes locoregional control while minimizing treatment-related side effects. In this article, we highlight considerations in target delineation, radiation dose, and the adoption of technological advances with the aim of optimizing the benefits of radiotherapy in NPC patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Current management and perspectives for locally advanced nasopharyngeal carcinoma
    Mnejja, W.
    Nouri, O.
    Fourati, N.
    Dhouib, F.
    Siala, W.
    Charfeddine, I.
    Khanfir, A.
    Farhat, L.
    Daoud, J.
    CANCER RADIOTHERAPIE, 2022, 26 (05): : 730 - 735
  • [22] Incidence of hypothyroidism after radiotherapy for nasopharyngeal carcinoma
    Şükran Ülger
    Zekeriya Ülger
    Ferah Yildiz
    Enis Özyar
    Medical Oncology, 2007, 24 : 91 - 94
  • [23] Radiomics and Deep Learning in Nasopharyngeal Carcinoma: A Review
    Wang, Zipei
    Fang, Mengjie
    Zhang, Jie
    Tang, Linquan
    Zhong, Lianzhen
    Li, Hailin
    Cao, Runnan
    Zhao, Xun
    Liu, Shengyuan
    Zhang, Ruofan
    Xie, Xuebin
    Mai, Haiqiang
    Qiu, Sufang
    Tian, Jie
    Dong, Di
    IEEE REVIEWS IN BIOMEDICAL ENGINEERING, 2024, 17 : 118 - 135
  • [24] STEREOTACTIC RADIOTHERAPY FOR LOCALLY RECURRENT NASOPHARYNGEAL CARCINOMA
    Leung, To-Wai
    Wong, Victy Y. W.
    Tung, Stewart Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : 734 - 741
  • [25] Impact of the radiotherapy rhythm on prognosis in nasopharyngeal carcinoma
    Li, Ying
    Chen, Xiaochuan
    Wu, Lishui
    Huang, Zongwei
    Xu, Siqi
    Hong, Xinyi
    Lai, Jinghua
    Qiu, Sufang
    Zheng, Xiong
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [26] Incidence of hypothyroidism after radiotherapy for nasopharyngeal carcinoma
    Ulger, Sukran
    Ulger, Zerkeriya
    Yildiz, Ferah
    Ozyar, Enis
    MEDICAL ONCOLOGY, 2007, 24 (01) : 91 - 94
  • [27] Late toxicity, evolving radiotherapy techniques, and quality of life in nasopharyngeal carcinoma
    Lastrucci, Luciana
    Bertocci, Silvia
    Bini, Vittorio
    Borghesi, Simona
    De Majo, Roberta
    Rampini, Andrea
    Pernici, Paola
    Gennari, Pietro Giovanni
    RADIOLOGIA MEDICA, 2017, 122 (04): : 303 - 308
  • [28] Outcomes of patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
    Yeh, Shyh-An
    Hwang, Tzer-Zen
    Wang, Chih-Chun
    Yang, Chuen-Chien
    Lien, Ching-Feng
    Wang, Chien-Chung
    Hsu, Tun-Yen
    Hsu, Ruey-Feng
    Shih, Yu-Chen
    Huang, Yaw-Chang
    Hsieh, Meng-Che
    Gau, Jhy-Shyan
    Chang, Liyun
    Lee, Tsair-Fwu
    JOURNAL OF RADIATION RESEARCH, 2021, 62 (03) : 438 - 447
  • [29] Choanal stenosis post radiotherapy for nasopharyngeal carcinoma: about an endoscopic management
    Lakhdar, Youssef
    Rochd, Sara
    Elbouderkaoui, Mohamed
    Rochdi, Youssef
    Nouri, Hassan
    Raji, Abdelaziz
    PAN AFRICAN MEDICAL JOURNAL, 2019, 34
  • [30] Definitive radiotherapy for nasopharyngeal carcinoma
    Mendenhall, William M.
    Morris, Christopher G.
    Hinerman, Russell W.
    Malyapa, Robert S.
    Amdur, Robert J.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (06): : 622 - 627